4
Changes in Ownership
Immunome Inc. Filed Acc 0001209191-23-058886
Options or other derivatives
- Chief Technology Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts Phil Noland Chief Technology Officer | 2023-12-13 | Grant or award · Stock option (right to buy) | +275,000 | 275,000 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…